窥得儿医药 QDEL 深 沪
等待开盘 11-05 09:30:00 美东时间
27.13
-0.580
-2.09%
华盛通- 最 高27.98
- 今 开27.34
- 成交量 128.99万股
- 最 低 26.79
- 昨 收 27.71
- 总市值 18.42亿
- 52周最高 49.45
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 22.05
- 委 比 -66.96%
- 总股本 6790.05万
- 历史最高 306.724
- 量 比 1.06
- 振 幅 4.29%
- 历史最低 12.35
- 每 手 1
- 风险率 6.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
52分钟前
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Adm...
11-03 20:00
Why Is Co-Diagnostics Stock Sinking Tuesday?
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
10-28 23:50
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring Geor...
10-24 06:45
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corpo...
10-17 08:30
美股大行评级 | 最高300美元，AMD获多家大行上调目标价！
今日重点评级关注：Maxim Group：维持Gain Therapeutics"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Icecure Medical"买入"评级，目标价从2美元升至2.5美元
10-08 09:14
Citigroup Downgrades QuidelOrtho to Neutral, Lowers Price Target to $33
Citigroup analyst Patrick Donnelly downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and lowers the price target from $40 to $33.
10-07 19:25
QuidelOrtho Expands QUICKVUE Portfolio With Launch Of Influenza Plus SARS Test Delivering Results In As Fast As 10 Minutes
Key Features and Benefits:Triple Detection Capability: Differentiates influenza A/B and COVID-19 in one test.Fast Results: Clear results available in as fast as 10 minutes at the point of care.Professional Use: Designed
09-22 19:13
QuidelOrtho Completes Debt Refinancing
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed fo...
08-22 04:30
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, welcomes Erich Wolff as Executive V...
08-20 04:05
